Contractor profile

Mckesson Corporation

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

prime recipient of federal awards · UEI S1RUKWWRYFL6 Source
$14.9B
Obligated
FY2026 · data still posting
6
Funding agencies
98%
From Veterans Affai…
0%
Non-competed
10
States
99%
In Texas
8
Industries

In FY2026, Mckesson Corporation received $14.9B in federal awards from 6 agencies, 98% of it from the Department of Veterans Affairs, with 99% of the work performed in Texas. Across FY2020 to FY2026 its recorded total is $68.1B. FY2026 ended Sep 30 and its data is still posting. Computed

Where this money comes from

Source
FUNDING AGENCIES
MCKESSON CORPORATION
Veterans Affairs
$14.6B
Justice
$0.2B
4 other agencies
$0.1B
Mckesson Corporation
$14.9B
FY2026 obligated
band width = obligations · FY2026 · source: USASpending.gov

Where the work lands

Source
Texas$14.8B
Oklahoma$112.7M
Georgia$971.7K
Pennsylvania$525.4K
Virginia$508.9K
Illinois$458K
West Virginia$367.5K
Mississippi$331.6K

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Mckesson Corporation received $14.9B in federal obligations in FY2026 (data still posting), compared with $11.9B in FY2025.
  • It ranked #7 among federal contractors by contract obligations in FY2026 (data still posting).
  • The Department of Veterans Affairs accounted for 97% of it.
  • Its largest recorded industry was Pharmaceutical Preparation Manufacturing, at $14.9B.

Obligations by year

Computed
$6.7B
FY20
$7.7B
FY21
$8.4B
FY22
$9.5B
FY23
$9B
FY24
$11.9B
FY25
$14.9B
FY26 partial
▲ 77%
FY20 to FY25

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 September36C24026K1012Department of Veterans Affairs$1.5B2026-09-012026-09-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 November36C24026K1002Department of Veterans Affairs$1.4B2025-11-012025-11-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 May36C24026K1008Department of Veterans Affairs$1.4B2026-05-012026-05-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 July36C24026K1010Department of Veterans Affairs$1.2B2026-07-012026-07-31Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 June36C24026K1009Department of Veterans Affairs$1.2B2026-06-012026-06-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 April36C24026K1007Department of Veterans Affairs$1.2B2026-04-012026-04-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 October36C24026K1001Department of Veterans Affairs$1.2B2025-10-012025-10-31Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 March36C24026K1006Department of Veterans Affairs$1.2B2026-03-012026-03-31Texas

Largest FY2026 awards

Awards that started in FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 September36C24026K1012Department of Veterans Affairs$1.5B2026-09-012026-09-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 November36C24026K1002Department of Veterans Affairs$1.4B2025-11-012025-11-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 May36C24026K1008Department of Veterans Affairs$1.4B2026-05-012026-05-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 July36C24026K1010Department of Veterans Affairs$1.2B2026-07-012026-07-31Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 June36C24026K1009Department of Veterans Affairs$1.2B2026-06-012026-06-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 April36C24026K1007Department of Veterans Affairs$1.2B2026-04-012026-04-30Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 October36C24026K1001Department of Veterans Affairs$1.2B2025-10-012025-10-31Texas
Express Report: Pharmaceutical Prime Vendor (PPV)FY2026 March36C24026K1006Department of Veterans Affairs$1.2B2026-03-012026-03-31Texas

What it does (NAICS / PSC)

Pharmaceutical Preparation Manufacturing$14.9B
Drugs and Druggists' Sundries Merchant Wholesalers$6.4M
Major Household Appliance Manufacturing$36.1K
Medicinal and Botanical Manufacturing$21.5K
Medical Laboratories$15K
General Medical and Surgical Hospitals$259

Competition

0%non-competed (often called no-bid), of $14.9B in contract obligations in FY2026Computed

This describes how contracts were awarded, not wrongdoing.

Similar federal contractors

Computed
Merck Sharp & Dohme LLC$2.3B
Pfizer Inc$1.1B
Glaxosmithkline, LLC$1.1B
Sanofi Vaccines US Inc.$734.4M
Emergent Biosolutions Canada Inc$118.3M
Exelan Pharmaceuticals Inc$96.2M
Canadian Commercial Corporation$16.4M
Trillamed LLC$1.1M

Corporate family

Single registration: no combined family.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.